Rocket Lab (RKLB) 4Q25 Beats Expectations on Revenue, Per Share Losses

(Long Beach, California) Rocket Lab (NASDAQ: RKLB) reported earnings after the close today (Feb. 26), posting better-than-expected 4Q25 sales and a slightly smaller adjusted per-share loss than expected.

Image from Rocket Lab’s 81st Electron launch on Jan. 30, 2026 courtesy of Rocket Lab on Instagram, @rocketlab.

RKLB shares fell slightly post-report, and are trading at $69.99 as of 5.05pm ET.

Quick rundown, per Sherwood News:

• Q4 revenue of $179.7 million vs. Wall Street’s expectation for $176.8 million.
• Full-year 2025 revenue of $602 million, up 38% yoy.
• Adjusted loss per share of -$0.09 vs. consensus of -$0.10.
• Adjusted EBITDA of -$17.4 million vs. analyst expectations of -$25.2 million. 
• Backlog grew 73% you to $1.85 billion.
• The company flew 21 launches in 2025 with a 100% success rate and secured an $816 million SDA prime contract.
• Rocket Lab guided Q1 2026 revenue of $185M–$200M and updated Neutron’s first launch target to Q4 2026 after a stage 1 tank test failure.
• Rocket Lab signed a multi-launch contract with BlackSky (NYSE: BKSY) for four dedicated Electron missions, bringing BlackSky’s total launches with Rocket Lab to 17 since 2019 and making Rocket Lab the company’s most prolific global launch provider.
• A manufacturing defect delayed the reusable Neutron rocket’s debut to Q4 2026, contributing to shares dipping 2% after hours despite strong margins and upbeat Q1 guidance. Neutron, a medium-lift reusable rocket that analysts say can compete with SpaceX‘s Falcon 9, was initially expected to make its debut in 2024 – the target was thereafter pushed back to 2025, and has now been moved to 2026, according to Morningstar.

Worth noting that Rocket Lab shares rose by 361% in 2024, and another 174% last year. Shares are down just over 4% ytd in 2026.

** Not investment advice; neither The FLY Report nor FLYJETS – nor any associated individual – is a registered investment adviser.